CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Iktos is revolutionizing drug discovery with an AI-driven platform that combines artificial intelligence and robotics to streamline the process. This closed-loop system aims to significantly reduce the time and costs associated with developing new medications by enhancing molecule design and synthesis.
Drug discovery is a lengthy and costly process, often exceeding a decade and involving investments upwards of €1.3bn.
Despite these efforts, a staggering 90% of drug candidates fail in clinical trials, never reaching patients.
This inefficiency underscores the urgent need for innovation in drug discovery methodologies.Iktos proposes a transformative approach with its closed-loop AI-guided autonomous drug discovery platform, leveraging generative AI and built-in synthetic accessibility.
This para…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
